VANCOUVER, BC, July 18, 2024 /CNW/ - 

TSX VENTURE COMPANIES

BULLETIN V2024-2216

PHARMACORP RX INC. ("PCRX")
[formerly PROTON CAPITAL CORP. ("PTN")]
BULLETIN TYPE: Prospectus-Share Offering, Name Change, Resume Trading
BULLETIN DATE:  July 18, 2024
TSX Venture Tier 2 Company

Resume Trading

Effective at the open, Monday, July 22, 2024, shares of the Company resumed trading, an announcement having been made on July 18, 2024 that the Company has completed the closing of the final tranche of the Prospectus Offering and will complete its name change to PharmaCorp Rx Inc. on July 22, 2024.

Prospectus-Share Offering

TSX Venture Exchange has been advised that closing of the final tranche of the Prospectus Offering occurred on July 18, 2024, for gross proceeds of $8,127,341.60. The Company completed the first tranche of the Prospectus Offering which occurred on June 6, 2024, for gross proceeds of $20,797,658.40.  In aggregate, the Company raised gross proceeds of $28,925,000 from 72,312,500 common shares at $0.40 per common share.

Financing Type:                         

Best Efforts Prospectus Offering

Gross Proceeds:                       

$8,127,341.60



Offering:                                   

20,318,354 Listed Shares



Offering Price:                         

$0.40 per Listed Share



Overallotment Option:               

The agent may purchase a maximum of 15,000,000 Listed Shares for overallotment purposes. Such option expired unexercised.



Disclosure:                               

Refer to the prospectus dated May 24, 2024, the Exchange Bulletin dated June 7, 2024, and the Company's news releases dated April 20, 2023, July 26, 2023, August 31, 2023, October 10, 2023, January 22, 2024, February 22, 2024, March 22, 2024, May 27, 2024, June 6, 2024. July 2, 2024, and July 18, 2024, which are available under the Company's profile on SEDAR+.


Name Change

Pursuant to a resolution passed by shareholders on January 22, 2024, effective July 22, 2024, the Company will change its name as follows: PharmaCorp Rx Inc.  There is no consolidation of capital.

Effective at the opening, Monday, July 22, 2024, the common shares of PharmaCorp Rx Inc. will commence trading on TSX Venture Exchange, and the common shares of Proton Capital Corp. will be delisted.  The Company is classified as a "Health and Personal Care Retailers" company.

Capitalization:                                                     

Unlimited        shares with no par value of which


116,953,575    shares are issued and outstanding

Escrow:                                                             

17,757,067      common shares

 

Transfer Agent:                                                                   

TSX Trust Company

Trading Symbol:                                                                 

PCRX (new)

CUSIP Number:                                                                   

71714X 10 5 (new)

_______________________________________

24/07/18 - TSX Venture Exchange Bulletins

TSX VENTURE COMPANIES

BULLETIN V2024-2217

BENTON RESOURCES INC. ("BEX") 
BULLETIN TYPE:  Halt
BULLETIN DATE:  July 18, 2024
TSX Venture Tier 1 Company

Effective at 12:12 p.m. PST, July 17, 2024, trading in the shares of the Company was halted, pending news; this regulatory halt is imposed by Investment Industry Regulatory Organization of Canada, the Market Regulator of the Exchange pursuant to the provisions of Section 10.9(1) of the Universal Market Integrity Rules.

_______________________________________

BULLETIN V2024-2218

BENTON RESOURCES INC. ("BEX")
BULLETIN TYPE:  Resume Trading
BULLETIN DATE:  July 18, 2024
TSX Venture Tier 1 Company

Effective at 5:00 a.m. PST, July 18, 2024, shares of the Company resumed trading, an announcement having been made.

_______________________________________

BULLETIN V2024-2219

CANTEX MINE DEVELOPMENT CORP. ("CD") 
BULLETIN TYPE:  Private Placement-Non-Brokered
BULLETIN DATE:  July 18, 2024
TSX Venture Tier 2 Company

Financing Type:                         

Non-Brokered Private Placement

Gross Proceeds:                       

$1,449,999.72

Offering:                                   

12,083,331 Listed Shares



Offering Price:                         

$0.12 per Listed Share



Public Disclosure:                     

Refer to the company's news release(s) dated June 3, 2024 and July 17, 2024

_______________________________________

BULLETIN V2024-2220

CHATHAM ROCK PHOSPHATE LIMITED ("NZP")
BULLETIN TYPE:  Private Placement-Non-Brokered
BULLETIN DATE:  July 18, 2024
TSX Venture Tier 2 Company

Financing Type:                         

Non-Brokered Private Placement

Gross Proceeds:                       

$70,240.00

Offering:                                   

878,000 Listed Shares



Offering Price:                         

$0.08 per Listed Share



Warrant Exercise Terms:           

N/A



Commissions in Securities:                                                                   

                                                            Shares              Warrants


Finders (Aggregate)                               N/A                      N/A



Disclosure:                               

Refer to the company's news release(s) dated June 28, 2024.

_______________________________________

BULLETIN V2024-2221

CONTAGIOUS GAMING INC. ("CNS") 
BULLETIN TYPE:  Halt
BULLETIN DATE:  July 18, 2024
TSX Venture Tier 2 Company

Effective at 4:44 a.m. PST, July 18, 2024, trading in the shares of the Company was halted, pending company contact; this regulatory halt is imposed by Investment Industry Regulatory Organization of Canada, the Market Regulator of the Exchange pursuant to the provisions of Section 10.9(1) of the Universal Market Integrity Rules.

_______________________________________

BULLETIN V2024-2222

MTB METALS CORP. ("MTB")
BULLETIN TYPE:  Shares for Debt
BULLETIN DATE:  July 18, 2024
TSX Venture Tier 2 Company

TSX Venture Exchange has accepted for filing the Company's proposal to issue 1,000,000 shares to settle outstanding debt for $40,000.

Number of Creditors:                 1 Creditor

Non-Arm's Length Party / Pro Group Participation:










Creditors

# of Creditors

Amount Owing

Deemed Price per Share

Aggregate # of Shares






Aggregate Non-Arm's Length Party Involvement:

N/A

N/A

N/A

N/A

Aggregate Pro Group Involvement:

1

$40,000

$0.04

1,000,000


The Company shall issue a news release when the shares are issued and the debt extinguished.

_______________________________________

BULLETIN V2024-2223

SCORPIO GOLD CORPORATION ("SGN")
BULLETIN TYPE:  Shares for Debt
BULLETIN DATE:  July 18, 2024
TSX Venture Tier 2 Company

TSX Venture Exchange has accepted for filing the Company's proposal to issue 132,150 shares to settle outstanding debt for $26,430.

Number of Creditors:                 1 Creditor

Non-Arm's Length Party / Pro Group Participation:










Creditors

# of Creditors

Amount Owing

Deemed Price per Share

Aggregate # of Shares






Aggregate Non-Arm's Length Party Involvement:

1

26,430

$0.20

132,150

Aggregate Pro Group Involvement:

N/A

N/A

N/A

N/A


The Company shall issue a news release when the shares are issued and the debt extinguished.

_______________________________________

BULLETIN V2024-2224

SILVER WOLF EXPLORATION LTD.  ("SWLF")
BULLETIN TYPE:  Shares for Debt
BULLETIN DATE: July 18, 2024
TSX Venture Tier 2 Company

TSX Venture Exchange has accepted for filing the Company's proposal to issue 65,455 shares to settle outstanding debt for $8,000.

Number of Creditors:                 1 Creditor

Non-Arm's Length Party / Pro Group Participation:










Creditors

# of Creditors

Amount Owing

Deemed Price per Share

Aggregate # of Shares






Aggregate Non-Arm's Length Party Involvement:

N/A

N/A

N/A

N/A

Aggregate Pro Group Involvement:

N/A

N/A

N/A

N/A


The Company shall issue a news release when the shares are issued and the debt extinguished.

_______________________________________

BULLETIN V2024-2225

ZONETAIL INC. ("ZONE")
BULLETIN TYPE: Private Placement – Non-Brokered
BULLETIN DATE: July 18, 2024
TSX Venture Tier 2 Company

TSX Venture Exchange has accepted for filing documentation with respect to a Non-Brokered Private Placement announced February 1, 2024:

Number of Shares:                   

10,393,400 common shares



Purchase Price:                         

$0.02 per share



Number of Placees:                   

13 Placees

 


Aggregate Cash
Amount

Aggregate #

of Shares

Aggregate #

of Warrants

Finder's Fee:

$840

N/A

42,000


Finder's Warrants Terms: Each warrant entitles the holder to purchase one common share at the price of $0.05 for period of three (3) years from the date of issuance.

For more information, please refer to the Company's news releases dated February 1, 2024, March 18, 2024, April 17, 2024, April 22, 2024, April 29, 2024 and May 3, 2024.

_______________________________________

SOURCE TSX Venture Exchange

Copyright 2024 Canada NewsWire